Prime Medicine, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $856 | $838 | $1,225 | $1,115 |
Gross Profit | -1,000 | 838 | -42,765 | -749 |
EBITDA | -48,798 | -46,732 | -48,701 | -51,513 |
EBIT | -50,654 | -48,608 | -50,582 | -53,377 |
Net Income | -49,122 | -46,079 | -50,582 | -52,591 |
Net Change In Cash | 856 | 838 | 1,225 | 1,115 |
Free Cash Flow | -42,924 | -37,546 | -35,286 | -42,984 |
Cash | 64,106 | 63,032 | 71,396 | 53,804 |
Basic Shares | 177,096 | 148,758 | 160,503 | 129,185 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $4,632 | $2,983 | $0 | $5,210 |
Gross Profit | -2,689 | 2,983 | -4,653 | -12,014 |
EBITDA | -195,758 | -196,339 | -186,639 | -114,320 |
EBIT | -201,142 | -202,467 | -191,292 | -116,544 |
Net Income | -201,142 | -195,882 | -198,133 | -121,821 |
Net Change In Cash | 4,632 | 2,983 | 0 | 5,210 |
Cost of Revenue | 2,571 | |||
Free Cash Flow | -167,095 | -130,159 | -174,136 | -147,922 |
Cash | 63,032 | 182,476 | 41,574 | 187,620 |
Basic Shares | 148,758 | 118,600 | 90,969 | 97,209 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.28 |
2025-12-31 | -$0.24 |
2025-09-30 | -$0.32 |
2025-06-30 | -$0.41 |